What does Docteur Flavien GRANDJEAN do?

Docteur Flavien GRANDJEAN is a specialist medical practice in Thimister-Clermont. Private Limited, started on 1 June 2023, 1 establishment.

What is the address of Docteur Flavien GRANDJEAN?

The registered office of Docteur Flavien GRANDJEAN is located at Chaussée Charlemagne 83 box -, 4890 Thimister-Clermont.

Is Docteur Flavien GRANDJEAN still active?

Yes. According to the CBE (16 September 2026) Docteur Flavien GRANDJEAN is active, legal situation “Normale toestand”, started on 1 June 2023.

Is Docteur Flavien GRANDJEAN registered on Peppol?

Yes, Docteur Flavien GRANDJEAN is registered on the Peppol network with ID 0208:0802325404.

What is the enterprise number of Docteur Flavien GRANDJEAN?

The enterprise number of Docteur Flavien GRANDJEAN is BE0802325404.

When was Docteur Flavien GRANDJEAN founded?

Docteur Flavien GRANDJEAN was founded on 1 June 2023.

Who are the directors of Docteur Flavien GRANDJEAN?

According to the 2025 annual accounts, the directors of Docteur Flavien GRANDJEAN are: Flavien GRANDJEAN.

Is Docteur Flavien GRANDJEAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 June 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Docteur Flavien GRANDJEAN make in 2025?

Docteur Flavien GRANDJEAN posted a profit after taxes of € 137,300 in financial year 2025.

What is the revenue of Docteur Flavien GRANDJEAN?

As a small company, Docteur Flavien GRANDJEAN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 195,661.

Docteur Flavien GRANDJEAN (Private Limited)

Dossier Docteur Flavien GRANDJEAN, printed on 16 September 2026 from databakkes.be/en/0802325404/docteur-flavien-grandjean. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 21 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Docteur Flavien GRANDJEAN from Thimister-Clermont, company number BE0802325404, closed financial year 2025 with a result of € 137,300 after tax. For that financial year Docteur Flavien GRANDJEAN recorded a gross margin of € 195,661 and equity of € 9,887. Compared with financial year 2024, the result moved from € 128,821 to € 137,300. Profitable, and profit is growing. The buffer shrank hard: equity is 93 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Shrank hard

€ 9,887

▼ 93% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 137,300

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 56,273

▼ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 260,970 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 41,836

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 44,250

▼ 22% vs 2024

€ 13,321 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,676

▲ € 2,428 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 81,092

▲ € 62,495 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 3,253 Gross margin 2023: € 3,253 First fiscal year in the series	€ 183,122 Gross margin 2024: € 183,122 ▲ € 179,869 vs 2023 (€ 3,253) Favourable step	€ 195,661 Gross margin 2025: € 195,661 ▲ 7% vs 2024 (€ 183,122) Favourable step	▲ 7%
Profit after taxes	€ 2,236 Profit after taxes 2023: € 2,236 First fiscal year in the series	€ 128,821 Profit after taxes 2024: € 128,821 ▲ € 126,585 vs 2023 (€ 2,236) Favourable step	€ 137,300 Profit after taxes 2025: € 137,300 ▲ 7% vs 2024 (€ 128,821) Favourable step	▲ 7%
Equity	€ 4,736 Equity 2023: € 4,736 First fiscal year in the series	€ 133,558 Equity 2024: € 133,558 ▲ € 128,821 vs 2023 (€ 4,736) Favourable step	€ 9,887 Equity 2025: € 9,887 ▼ 93% vs 2024 (€ 133,558) Unfavourable step	▼ 93%
Total debts	€ 11,632 Total debts 2023: € 11,632 First fiscal year in the series	€ 75,848 Total debts 2024: € 75,848 ▲ € 64,216 vs 2023 (€ 11,632) Unfavourable step	€ 337,813 Total debts 2025: € 337,813 ▲ € 261,965 vs 2024 (€ 75,848) Unfavourable step	▲ € 261,965
Cash	€ 4,822 Cash 2023: € 4,822 First fiscal year in the series	€ 119,597 Cash 2024: € 119,597 ▲ € 114,775 vs 2023 (€ 4,822) Favourable step	€ 56,273 Cash 2025: € 56,273 ▼ 53% vs 2024 (€ 119,597) Unfavourable step	▼ 53%
Retained profit	€ 2,236 Retained profit 2023: € 2,236 First fiscal year in the series	€ 131,058 Retained profit 2024: € 131,058 ▲ € 128,821 vs 2023 (€ 2,236) Favourable step	€ 7,387 Retained profit 2025: € 7,387 ▼ 94% vs 2024 (€ 131,058) Unfavourable step	▼ 94%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 260,970 Dividend 2025: € 260,970 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2023: € 0 First fiscal year in the series	€ 57,003 Bank debt 2024: € 57,003 Unchanged (€ 0) Unfavourable step	€ 44,250 Bank debt 2025: € 44,250 ▼ 22% vs 2024 (€ 57,003) Favourable step	▼ 22%
Balance sheet total	€ 16,368 Balance sheet total 2023: € 16,368 First fiscal year in the series	€ 209,406 Balance sheet total 2024: € 209,406 ▲ € 193,037 vs 2023 (€ 16,368) Unchanged	€ 347,700 Balance sheet total 2025: € 347,700 ▲ 66% vs 2024 (€ 209,406) Unchanged	▲ 66%

Key figures of Docteur Flavien GRANDJEAN, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Docteur Flavien GRANDJEAN?

What happened at Docteur Flavien GRANDJEAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 137,300 (▲ 7% vs 2024). Source: NBB ↗
Jun 1, 2023 New establishment in Thimister-Clermont. KBO
Jun 1, 2023 Start of the company according to the CBE. KBO

In short

From € 2,236 profit in 2023 to € 137,300 profit in 2025.

Paid € 79,614 in corporate taxes since 2023.

Best year ever: 2025, with € 137,300 profit.

Paid out € 260,970 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Docteur Flavien GRANDJEAN? We notify you, reason included.

Follow Docteur Flavien GRANDJEAN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Flavien GRANDJEAN

Docteur Flavien GRANDJEAN

Behind Docteur Flavien GRANDJEAN is Flavien GRANDJEAN.

See the full network in the app

Directors

According to the 2025 annual accounts

Flavien GRANDJEAN

Managing director

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée Charlemagne 83 box -

4890 Thimister-Clermont

2.346.085.649

Chaussée Charlemagne 83

4890 Thimister-Clermont

Active since 1 June 2023

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ADREA ANESTHESIA

€ 1,280 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0802.325.404
VAT number: BE 0802.325.404
Registered office: Chaussée Charlemagne 83 bus -, 4890 Thimister-Clermont
Names & denominations: Docteur Flavien GRANDJEAN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 June 2023
Peppol: Active · Active since 13 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗